Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Barreira AA, Brooks JB, Claudino R, Correa EC, Ferreira ML, Finkelsztejn A, Finkelsztejn J, da Gama PD, Goncalves MV, Guerreiro CT, da Cunha Matta AP, Marques VD, Rizo Morales R, Parolin MF, de Castro Ribeiro M, Ribeiro TA, Ruocco HH, Sato H, Scherpenhuijzen S, Siquineli F, de Carvalho Sousa NA, Varela DL, Tauil CB, Winckler TC.
Fragoso YD, et al. Among authors: scherpenhuijzen s.
NeuroRehabilitation. 2016 Jun 30;39(2):301-4. doi: 10.3233/NRE-161361.
NeuroRehabilitation. 2016.
PMID: 27372365